THE VALUE OF CLINICAL TRIAL RESEARCH FOR ERCC1 TESTING IN STAGE I NON-SMALL CELL LUNG CANCER (NSCLC)

被引:0
|
作者
Roth, Joshua A. [1 ]
Carlson, Josh J. [1 ]
Steuten, Lotte [2 ]
Ramsey, Scott D. [3 ]
Veenstra, David L. [1 ]
机构
[1] Univ Washington, Seattle, WA 98195 USA
[2] Univ Twente, NL-7500 AE Enschede, Netherlands
[3] Fred Hutchinson Canc Res Ctr, Seattle, WA USA
关键词
ERCC1; Value of Research; Non-small cell lung cancer;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:S398 / S399
页数:2
相关论文
共 50 条
  • [21] ERCC1 protein as a guide for individualized therapy of late-stage advanced non-small cell lung cancer
    Gao, Zhiqiang
    Han, Baohui
    Shen, Jie
    Gu, Aiqin
    Qi, Dajiang
    Huang, Jinsu
    Shi, Chunlei
    Xiong, Liwen
    Zhao, Yizhuo
    Jiang, Liyan
    Wang, Huimin
    Chen, Yurong
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2011, 2 (05) : 811 - 815
  • [22] ERCC1 expression by immunohistochemistry and EGFR mutations in resected non-small cell lung cancer
    Lee, Kyung-Hun
    Min, Hye Sook
    Han, Sae-Won
    Oh, Do-Youn
    Lee, Se-Hoon
    Kim, Dong-Wan
    Im, Seock-Ah
    Chung, Doo Hyun
    Kim, Young Tale
    Kim, Tae-You
    Heo, Dae Seog
    Bang, Yung-Jue
    Sung, Sook Whan
    Kim, Joo Hyun
    LUNG CANCER, 2008, 60 (03) : 401 - 407
  • [23] Proton therapy for stage I non-small cell lung cancer (NSCLC)
    Nihei, K
    Ogino, T
    Ishikura, S
    Nishimura, H
    Kawashima, M
    Arahira, S
    Onozawa, M
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 60 (01): : S282 - S282
  • [24] Prognostic value of ERCC1, RRM1, and TS proteins in patients with resected non-small cell lung cancer
    Yu-Wen He
    Mei-Ling Zhao
    Xin-Yun Yang
    Jun Zeng
    Qiu-Hua Deng
    Jian-Xing He
    Cancer Chemotherapy and Pharmacology, 2015, 75 : 861 - 867
  • [25] Prognostic value of ERCC1, RRM1, and TS proteins in patients with resected non-small cell lung cancer
    He, Yu-Wen
    Zhao, Mei-Ling
    Yang, Xin-Yun
    Zeng, Jun
    Deng, Qiu-Hua
    He, Jian-Xing
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 75 (04) : 861 - 867
  • [26] ERCC1 expression by immunohistochemistry and EGFR mutations in resected non-small cell lung cancer
    Lee, K.
    Han, S.
    Min, H.
    Oh, D.
    Lee, S.
    Kim, D.
    Kim, Y.
    Kim, T.
    Heo, D.
    Bang, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [27] ERCC1 Is a Predictive Biomarker for Non-small Cell Lung Cancer But Is Antibody-dependent
    Okimoto, Tamio
    Tsubata, Yukari
    Tanino, Ryosuke
    Nakao, Mika
    Hotta, Takamasa
    Hamaguchi, Megumi
    Hamaguchi, Shunichi
    Araki, Asuka
    Isobe, Takeshi
    ANTICANCER RESEARCH, 2021, 41 (05) : 2653 - 2660
  • [28] ERCC1 gene copy number variations in resected non-small cell lung cancer
    Friboulet, Luc
    Olaussen, Ken A.
    Valent, Alexander
    Tang, Ximing
    Tang, Tao
    Li, Yuanyuan
    Behrens, Carmen
    Vielh, Philippe
    Robin, Angelique
    Goubar, Aicha
    Validire, Pierre
    Wistuba, Ignacio
    Soria, Jean-Charles
    CANCER RESEARCH, 2012, 72
  • [29] ERCC1 expression is a predictor of survival in resected patients with non-small cell lung cancer
    Simon, GR
    Sharma, S
    Cantor, A
    Smith, P
    Bepler, G
    CHEST, 2005, 127 (03) : 978 - 983
  • [30] HER-2/NEU and ERCC1 in advanced non-small cell lung cancer
    Yoo, J.
    HISTOPATHOLOGY, 2010, 57 : 220 - 220